Therefore we used a comprehensive approach to genetically approach to inhibit the pathways in the tumor cells by expression of HIF-1α shRNA and a dominant-negative TβRII, which then were analyzed an in vivo bone metastasis model. The gene discussed is TGFBR2; the disease is neoplasm.